nodes	percent_of_prediction	percent_of_DWPC	metapath
Bexarotene—RXRG—RXR and RAR heterodimerization with other nuclear receptor—THRA—hypothyroidism	0.0314	0.0829	CbGpPWpGaD
Bexarotene—RXRB—RXR and RAR heterodimerization with other nuclear receptor—THRA—hypothyroidism	0.0295	0.078	CbGpPWpGaD
Bexarotene—RXRG—Nuclear Receptors—THRA—hypothyroidism	0.0232	0.0612	CbGpPWpGaD
Bexarotene—RXRB—Nuclear Receptors—THRA—hypothyroidism	0.0218	0.0576	CbGpPWpGaD
Bexarotene—RXRG—RXR and RAR heterodimerization with other nuclear receptor—THRB—hypothyroidism	0.0202	0.0534	CbGpPWpGaD
Bexarotene—RXRB—RXR and RAR heterodimerization with other nuclear receptor—THRB—hypothyroidism	0.019	0.0502	CbGpPWpGaD
Bexarotene—RXRG—Nuclear Receptor transcription pathway—THRA—hypothyroidism	0.0183	0.0484	CbGpPWpGaD
Bexarotene—RXRB—Nuclear Receptor transcription pathway—THRA—hypothyroidism	0.0172	0.0455	CbGpPWpGaD
Bexarotene—Hyperthyroidism—Levothyroxine—hypothyroidism	0.017	0.037	CcSEcCtD
Bexarotene—Hyperthyroidism—Dextrothyroxine—hypothyroidism	0.017	0.037	CcSEcCtD
Bexarotene—RXRA—RXR and RAR heterodimerization with other nuclear receptor—THRA—hypothyroidism	0.0154	0.0406	CbGpPWpGaD
Bexarotene—RXRG—Nuclear Receptors—THRB—hypothyroidism	0.0149	0.0394	CbGpPWpGaD
Bexarotene—RXRB—Nuclear Receptors—THRB—hypothyroidism	0.014	0.0371	CbGpPWpGaD
Bexarotene—Hyperthyroidism—Liotrix—hypothyroidism	0.0125	0.0272	CcSEcCtD
Bexarotene—CYP2C9—urine—hypothyroidism	0.0123	0.0767	CbGeAlD
Bexarotene—RXRG—Nuclear Receptor transcription pathway—THRB—hypothyroidism	0.0118	0.0312	CbGpPWpGaD
Bexarotene—RXRG—heart—hypothyroidism	0.0115	0.0712	CbGeAlD
Bexarotene—RXRA—Nuclear Receptors—THRA—hypothyroidism	0.0113	0.03	CbGpPWpGaD
Bexarotene—RXRB—Nuclear Receptor transcription pathway—THRB—hypothyroidism	0.0111	0.0293	CbGpPWpGaD
Bexarotene—Cardiac failure congestive—Liothyronine—hypothyroidism	0.011	0.0238	CcSEcCtD
Bexarotene—RXRG—cardiovascular system—hypothyroidism	0.0108	0.0672	CbGeAlD
Bexarotene—RXRB—heart—hypothyroidism	0.0108	0.0669	CbGeAlD
Bexarotene—RXRA—YAP1- and WWTR1 (TAZ)-stimulated gene expression—NKX2-5—hypothyroidism	0.01	0.0265	CbGpPWpGaD
Bexarotene—RXRA—RXR and RAR heterodimerization with other nuclear receptor—THRB—hypothyroidism	0.00991	0.0262	CbGpPWpGaD
Bexarotene—RXRG—pituitary gland—hypothyroidism	0.00957	0.0595	CbGeAlD
Bexarotene—Hypernatraemia—Liotrix—hypothyroidism	0.00942	0.0204	CcSEcCtD
Bexarotene—CYP3A4—urine—hypothyroidism	0.00941	0.0585	CbGeAlD
Bexarotene—RXRA—female gonad—hypothyroidism	0.00908	0.0564	CbGeAlD
Bexarotene—RXRA—Nuclear Receptor transcription pathway—THRA—hypothyroidism	0.00897	0.0237	CbGpPWpGaD
Bexarotene—RXRG—adrenal gland—hypothyroidism	0.00855	0.0531	CbGeAlD
Bexarotene—Angina pectoris—Liothyronine—hypothyroidism	0.00838	0.0182	CcSEcCtD
Bexarotene—RXRG—thyroid gland—hypothyroidism	0.00825	0.0513	CbGeAlD
Bexarotene—RXRB—adrenal gland—hypothyroidism	0.00804	0.05	CbGeAlD
Bexarotene—RXRB—thyroid gland—hypothyroidism	0.00776	0.0482	CbGeAlD
Bexarotene—RXRA—liver—hypothyroidism	0.00761	0.0473	CbGeAlD
Bexarotene—RXRB—female gonad—hypothyroidism	0.00749	0.0466	CbGeAlD
Bexarotene—RXRA—Nuclear Receptors—THRB—hypothyroidism	0.00731	0.0193	CbGpPWpGaD
Bexarotene—RXRG—testis—hypothyroidism	0.00707	0.044	CbGeAlD
Bexarotene—RXRB—testis—hypothyroidism	0.00665	0.0413	CbGeAlD
Bexarotene—Coagulopathy—Liotrix—hypothyroidism	0.00636	0.0138	CcSEcCtD
Bexarotene—RXRB—liver—hypothyroidism	0.00628	0.0391	CbGeAlD
Bexarotene—Arrhythmia—Liothyronine—hypothyroidism	0.00615	0.0133	CcSEcCtD
Bexarotene—RXRB—cerebellum—hypothyroidism	0.00614	0.0382	CbGeAlD
Bexarotene—RXRA—Nuclear Receptor transcription pathway—THRB—hypothyroidism	0.00578	0.0153	CbGpPWpGaD
Bexarotene—Cellulitis—Liotrix—hypothyroidism	0.00545	0.0118	CcSEcCtD
Bexarotene—Hypocalcaemia—Liotrix—hypothyroidism	0.00541	0.0117	CcSEcCtD
Bexarotene—Cardiac failure congestive—Dextrothyroxine—hypothyroidism	0.00539	0.0117	CcSEcCtD
Bexarotene—Cardiac failure congestive—Levothyroxine—hypothyroidism	0.00539	0.0117	CcSEcCtD
Bexarotene—Creatinine increased—Liotrix—hypothyroidism	0.0052	0.0113	CcSEcCtD
Bexarotene—Increased appetite—Dextrothyroxine—hypothyroidism	0.0052	0.0113	CcSEcCtD
Bexarotene—Increased appetite—Levothyroxine—hypothyroidism	0.0052	0.0113	CcSEcCtD
Bexarotene—Hypertension—Liothyronine—hypothyroidism	0.00517	0.0112	CcSEcCtD
Bexarotene—RXRG—Generic Transcription Pathway—ZNF764—hypothyroidism	0.00491	0.013	CbGpPWpGaD
Bexarotene—Affect lability—Dextrothyroxine—hypothyroidism	0.00481	0.0104	CcSEcCtD
Bexarotene—Affect lability—Levothyroxine—hypothyroidism	0.00481	0.0104	CcSEcCtD
Bexarotene—Tachycardia—Liothyronine—hypothyroidism	0.00477	0.0104	CcSEcCtD
Bexarotene—Fluid retention—Liotrix—hypothyroidism	0.0047	0.0102	CcSEcCtD
Bexarotene—Mood swings—Levothyroxine—hypothyroidism	0.00463	0.01	CcSEcCtD
Bexarotene—Mood swings—Dextrothyroxine—hypothyroidism	0.00463	0.01	CcSEcCtD
Bexarotene—RXRB—Generic Transcription Pathway—ZNF764—hypothyroidism	0.00461	0.0122	CbGpPWpGaD
Bexarotene—Dehydration—Dextrothyroxine—hypothyroidism	0.00455	0.00986	CcSEcCtD
Bexarotene—Dehydration—Levothyroxine—hypothyroidism	0.00455	0.00986	CcSEcCtD
Bexarotene—Muscular weakness—Levothyroxine—hypothyroidism	0.00431	0.00936	CcSEcCtD
Bexarotene—Muscular weakness—Dextrothyroxine—hypothyroidism	0.00431	0.00936	CcSEcCtD
Bexarotene—Sepsis—Liotrix—hypothyroidism	0.0043	0.00933	CcSEcCtD
Bexarotene—Dysphagia—Dextrothyroxine—hypothyroidism	0.00422	0.00917	CcSEcCtD
Bexarotene—Dysphagia—Levothyroxine—hypothyroidism	0.00422	0.00917	CcSEcCtD
Bexarotene—Angina pectoris—Levothyroxine—hypothyroidism	0.00411	0.00893	CcSEcCtD
Bexarotene—Angina pectoris—Dextrothyroxine—hypothyroidism	0.00411	0.00893	CcSEcCtD
Bexarotene—Cardiac failure congestive—Liotrix—hypothyroidism	0.00396	0.0086	CcSEcCtD
Bexarotene—Body temperature increased—Liothyronine—hypothyroidism	0.00387	0.00839	CcSEcCtD
Bexarotene—RXRA—The citric acid (TCA) cycle and respiratory electron transport—ATP5O—hypothyroidism	0.00385	0.0102	CbGpPWpGaD
Bexarotene—Increased appetite—Liotrix—hypothyroidism	0.00383	0.0083	CcSEcCtD
Bexarotene—Weight decreased—Levothyroxine—hypothyroidism	0.00382	0.00829	CcSEcCtD
Bexarotene—Weight decreased—Dextrothyroxine—hypothyroidism	0.00382	0.00829	CcSEcCtD
Bexarotene—Renal impairment—Liotrix—hypothyroidism	0.00378	0.0082	CcSEcCtD
Bexarotene—Cerebrovascular accident—Liotrix—hypothyroidism	0.00367	0.00796	CcSEcCtD
Bexarotene—Sweating—Levothyroxine—hypothyroidism	0.00361	0.00784	CcSEcCtD
Bexarotene—Sweating—Dextrothyroxine—hypothyroidism	0.00361	0.00784	CcSEcCtD
Bexarotene—Affect lability—Liotrix—hypothyroidism	0.00354	0.00768	CcSEcCtD
Bexarotene—Mood swings—Liotrix—hypothyroidism	0.00341	0.00739	CcSEcCtD
Bexarotene—Blood creatinine increased—Liotrix—hypothyroidism	0.00337	0.00731	CcSEcCtD
Bexarotene—Dehydration—Liotrix—hypothyroidism	0.00334	0.00726	CcSEcCtD
Bexarotene—Hypokalaemia—Liotrix—hypothyroidism	0.00327	0.0071	CcSEcCtD
Bexarotene—Muscular weakness—Liotrix—hypothyroidism	0.00317	0.00688	CcSEcCtD
Bexarotene—CYP2C9—heart—hypothyroidism	0.00316	0.0197	CbGeAlD
Bexarotene—RXRG—Generic Transcription Pathway—THRA—hypothyroidism	0.00316	0.00836	CbGpPWpGaD
Bexarotene—RXRA—NRF2 pathway—SLC5A7—hypothyroidism	0.00315	0.00833	CbGpPWpGaD
Bexarotene—Abdominal distension—Liotrix—hypothyroidism	0.00313	0.00679	CcSEcCtD
Bexarotene—Dysphagia—Liotrix—hypothyroidism	0.00311	0.00674	CcSEcCtD
Bexarotene—Angina pectoris—Liotrix—hypothyroidism	0.00303	0.00657	CcSEcCtD
Bexarotene—Arrhythmia—Dextrothyroxine—hypothyroidism	0.00302	0.00656	CcSEcCtD
Bexarotene—Arrhythmia—Levothyroxine—hypothyroidism	0.00302	0.00656	CcSEcCtD
Bexarotene—Bronchitis—Liotrix—hypothyroidism	0.00299	0.00649	CcSEcCtD
Bexarotene—Alopecia—Levothyroxine—hypothyroidism	0.00299	0.00648	CcSEcCtD
Bexarotene—Alopecia—Dextrothyroxine—hypothyroidism	0.00299	0.00648	CcSEcCtD
Bexarotene—CYP2C9—cardiovascular system—hypothyroidism	0.00298	0.0186	CbGeAlD
Bexarotene—RXRA—BMAL1:CLOCK,NPAS2 activates circadian gene expression—AVP—hypothyroidism	0.00297	0.00786	CbGpPWpGaD
Bexarotene—RXRB—Generic Transcription Pathway—THRA—hypothyroidism	0.00297	0.00786	CbGpPWpGaD
Bexarotene—RXRA—Endogenous sterols—POMC—hypothyroidism	0.00289	0.00764	CbGpPWpGaD
Bexarotene—Tension—Levothyroxine—hypothyroidism	0.00289	0.00627	CcSEcCtD
Bexarotene—Tension—Dextrothyroxine—hypothyroidism	0.00289	0.00627	CcSEcCtD
Bexarotene—Nervousness—Levothyroxine—hypothyroidism	0.00286	0.0062	CcSEcCtD
Bexarotene—Nervousness—Dextrothyroxine—hypothyroidism	0.00286	0.0062	CcSEcCtD
Bexarotene—Weight decreased—Liotrix—hypothyroidism	0.00281	0.0061	CcSEcCtD
Bexarotene—Agitation—Dextrothyroxine—hypothyroidism	0.0027	0.00587	CcSEcCtD
Bexarotene—Agitation—Levothyroxine—hypothyroidism	0.0027	0.00587	CcSEcCtD
Bexarotene—Sweating—Liotrix—hypothyroidism	0.00266	0.00576	CcSEcCtD
Bexarotene—Palpitations—Levothyroxine—hypothyroidism	0.0026	0.00564	CcSEcCtD
Bexarotene—Palpitations—Dextrothyroxine—hypothyroidism	0.0026	0.00564	CcSEcCtD
Bexarotene—Arthralgia—Dextrothyroxine—hypothyroidism	0.00251	0.00544	CcSEcCtD
Bexarotene—Arthralgia—Levothyroxine—hypothyroidism	0.00251	0.00544	CcSEcCtD
Bexarotene—Anxiety—Dextrothyroxine—hypothyroidism	0.0025	0.00542	CcSEcCtD
Bexarotene—Anxiety—Levothyroxine—hypothyroidism	0.0025	0.00542	CcSEcCtD
Bexarotene—Hypoaesthesia—Liotrix—hypothyroidism	0.00247	0.00537	CcSEcCtD
Bexarotene—Confusional state—Levothyroxine—hypothyroidism	0.00242	0.00526	CcSEcCtD
Bexarotene—Confusional state—Dextrothyroxine—hypothyroidism	0.00242	0.00526	CcSEcCtD
Bexarotene—RXRA—Generic Transcription Pathway—ZNF764—hypothyroidism	0.0024	0.00635	CbGpPWpGaD
Bexarotene—Shock—Levothyroxine—hypothyroidism	0.00236	0.00513	CcSEcCtD
Bexarotene—Shock—Dextrothyroxine—hypothyroidism	0.00236	0.00513	CcSEcCtD
Bexarotene—RXRG—Gene Expression—ZNF764—hypothyroidism	0.00236	0.00624	CbGpPWpGaD
Bexarotene—CYP2C9—blood—hypothyroidism	0.00236	0.0147	CbGeAlD
Bexarotene—Tachycardia—Dextrothyroxine—hypothyroidism	0.00234	0.00509	CcSEcCtD
Bexarotene—Tachycardia—Levothyroxine—hypothyroidism	0.00234	0.00509	CcSEcCtD
Bexarotene—Hyperhidrosis—Levothyroxine—hypothyroidism	0.00232	0.00504	CcSEcCtD
Bexarotene—Hyperhidrosis—Dextrothyroxine—hypothyroidism	0.00232	0.00504	CcSEcCtD
Bexarotene—RXRG—Generic Transcription Pathway—NKX2-5—hypothyroidism	0.00225	0.00595	CbGpPWpGaD
Bexarotene—Arrhythmia—Liotrix—hypothyroidism	0.00222	0.00482	CcSEcCtD
Bexarotene—RXRB—Gene Expression—ZNF764—hypothyroidism	0.00222	0.00587	CbGpPWpGaD
Bexarotene—Alopecia—Liotrix—hypothyroidism	0.0022	0.00477	CcSEcCtD
Bexarotene—Musculoskeletal discomfort—Dextrothyroxine—hypothyroidism	0.00219	0.00475	CcSEcCtD
Bexarotene—Musculoskeletal discomfort—Levothyroxine—hypothyroidism	0.00219	0.00475	CcSEcCtD
Bexarotene—Insomnia—Dextrothyroxine—hypothyroidism	0.00217	0.00472	CcSEcCtD
Bexarotene—Insomnia—Levothyroxine—hypothyroidism	0.00217	0.00472	CcSEcCtD
Bexarotene—RXRA—Circadian Clock—AVP—hypothyroidism	0.00217	0.00572	CbGpPWpGaD
Bexarotene—Dyspnoea—Levothyroxine—hypothyroidism	0.00214	0.00465	CcSEcCtD
Bexarotene—Dyspnoea—Dextrothyroxine—hypothyroidism	0.00214	0.00465	CcSEcCtD
Bexarotene—Flatulence—Liotrix—hypothyroidism	0.00213	0.00463	CcSEcCtD
Bexarotene—Tension—Liotrix—hypothyroidism	0.00212	0.00461	CcSEcCtD
Bexarotene—Dysgeusia—Liotrix—hypothyroidism	0.00212	0.0046	CcSEcCtD
Bexarotene—RXRB—Generic Transcription Pathway—NKX2-5—hypothyroidism	0.00212	0.0056	CbGpPWpGaD
Bexarotene—Nervousness—Liotrix—hypothyroidism	0.0021	0.00456	CcSEcCtD
Bexarotene—Fatigue—Dextrothyroxine—hypothyroidism	0.00207	0.00449	CcSEcCtD
Bexarotene—Fatigue—Levothyroxine—hypothyroidism	0.00207	0.00449	CcSEcCtD
Bexarotene—RXRG—Generic Transcription Pathway—THRB—hypothyroidism	0.00204	0.00538	CbGpPWpGaD
Bexarotene—Agitation—Liotrix—hypothyroidism	0.00199	0.00432	CcSEcCtD
Bexarotene—Feeling abnormal—Levothyroxine—hypothyroidism	0.00198	0.0043	CcSEcCtD
Bexarotene—Feeling abnormal—Dextrothyroxine—hypothyroidism	0.00198	0.0043	CcSEcCtD
Bexarotene—Gastrointestinal pain—Dextrothyroxine—hypothyroidism	0.00196	0.00426	CcSEcCtD
Bexarotene—Gastrointestinal pain—Levothyroxine—hypothyroidism	0.00196	0.00426	CcSEcCtD
Bexarotene—Syncope—Liotrix—hypothyroidism	0.00194	0.00421	CcSEcCtD
Bexarotene—RXRB—Generic Transcription Pathway—THRB—hypothyroidism	0.00192	0.00506	CbGpPWpGaD
Bexarotene—Palpitations—Liotrix—hypothyroidism	0.00191	0.00415	CcSEcCtD
Bexarotene—Loss of consciousness—Liotrix—hypothyroidism	0.0019	0.00413	CcSEcCtD
Bexarotene—Body temperature increased—Levothyroxine—hypothyroidism	0.0019	0.00412	CcSEcCtD
Bexarotene—Abdominal pain—Dextrothyroxine—hypothyroidism	0.0019	0.00412	CcSEcCtD
Bexarotene—Body temperature increased—Dextrothyroxine—hypothyroidism	0.0019	0.00412	CcSEcCtD
Bexarotene—Abdominal pain—Levothyroxine—hypothyroidism	0.0019	0.00412	CcSEcCtD
Bexarotene—Hypertension—Liotrix—hypothyroidism	0.00187	0.00406	CcSEcCtD
Bexarotene—CYP2C9—liver—hypothyroidism	0.00185	0.0115	CbGeAlD
Bexarotene—Chest pain—Liotrix—hypothyroidism	0.00184	0.004	CcSEcCtD
Bexarotene—Arthralgia—Liotrix—hypothyroidism	0.00184	0.004	CcSEcCtD
Bexarotene—Anxiety—Liotrix—hypothyroidism	0.00184	0.00399	CcSEcCtD
Bexarotene—CYP3A4—blood—hypothyroidism	0.0018	0.0112	CbGeAlD
Bexarotene—Confusional state—Liotrix—hypothyroidism	0.00178	0.00387	CcSEcCtD
Bexarotene—Oedema—Liotrix—hypothyroidism	0.00177	0.00383	CcSEcCtD
Bexarotene—Infection—Liotrix—hypothyroidism	0.00176	0.00381	CcSEcCtD
Bexarotene—Shock—Liotrix—hypothyroidism	0.00174	0.00377	CcSEcCtD
Bexarotene—Tachycardia—Liotrix—hypothyroidism	0.00172	0.00374	CcSEcCtD
Bexarotene—Asthenia—Dextrothyroxine—hypothyroidism	0.00172	0.00374	CcSEcCtD
Bexarotene—Asthenia—Levothyroxine—hypothyroidism	0.00172	0.00374	CcSEcCtD
Bexarotene—Hyperhidrosis—Liotrix—hypothyroidism	0.00171	0.00371	CcSEcCtD
Bexarotene—Pruritus—Levothyroxine—hypothyroidism	0.0017	0.00369	CcSEcCtD
Bexarotene—Pruritus—Dextrothyroxine—hypothyroidism	0.0017	0.00369	CcSEcCtD
Bexarotene—Anorexia—Liotrix—hypothyroidism	0.00168	0.00366	CcSEcCtD
Bexarotene—Diarrhoea—Dextrothyroxine—hypothyroidism	0.00164	0.00357	CcSEcCtD
Bexarotene—Diarrhoea—Levothyroxine—hypothyroidism	0.00164	0.00357	CcSEcCtD
Bexarotene—Musculoskeletal discomfort—Liotrix—hypothyroidism	0.00161	0.00349	CcSEcCtD
Bexarotene—Insomnia—Liotrix—hypothyroidism	0.0016	0.00347	CcSEcCtD
Bexarotene—Paraesthesia—Liotrix—hypothyroidism	0.00159	0.00344	CcSEcCtD
Bexarotene—Dyspnoea—Liotrix—hypothyroidism	0.00158	0.00342	CcSEcCtD
Bexarotene—RXRA—Generic Transcription Pathway—THRA—hypothyroidism	0.00155	0.00409	CbGpPWpGaD
Bexarotene—Decreased appetite—Liotrix—hypothyroidism	0.00154	0.00333	CcSEcCtD
Bexarotene—Vomiting—Dextrothyroxine—hypothyroidism	0.00153	0.00331	CcSEcCtD
Bexarotene—Vomiting—Levothyroxine—hypothyroidism	0.00153	0.00331	CcSEcCtD
Bexarotene—Fatigue—Liotrix—hypothyroidism	0.00152	0.00331	CcSEcCtD
Bexarotene—RXRG—Gene Expression—THRA—hypothyroidism	0.00152	0.00402	CbGpPWpGaD
Bexarotene—Rash—Levothyroxine—hypothyroidism	0.00151	0.00329	CcSEcCtD
Bexarotene—Rash—Dextrothyroxine—hypothyroidism	0.00151	0.00329	CcSEcCtD
Bexarotene—Dermatitis—Dextrothyroxine—hypothyroidism	0.00151	0.00328	CcSEcCtD
Bexarotene—Dermatitis—Levothyroxine—hypothyroidism	0.00151	0.00328	CcSEcCtD
Bexarotene—Constipation—Liotrix—hypothyroidism	0.00151	0.00328	CcSEcCtD
Bexarotene—Headache—Levothyroxine—hypothyroidism	0.0015	0.00327	CcSEcCtD
Bexarotene—Headache—Dextrothyroxine—hypothyroidism	0.0015	0.00327	CcSEcCtD
Bexarotene—Feeling abnormal—Liotrix—hypothyroidism	0.00146	0.00316	CcSEcCtD
Bexarotene—Gastrointestinal pain—Liotrix—hypothyroidism	0.00144	0.00314	CcSEcCtD
Bexarotene—RXRB—Gene Expression—THRA—hypothyroidism	0.00143	0.00378	CbGpPWpGaD
Bexarotene—Nausea—Dextrothyroxine—hypothyroidism	0.00143	0.0031	CcSEcCtD
Bexarotene—Nausea—Levothyroxine—hypothyroidism	0.00143	0.0031	CcSEcCtD
Bexarotene—RXRG—Adipogenesis—IGF1—hypothyroidism	0.00142	0.00375	CbGpPWpGaD
Bexarotene—CYP3A4—liver—hypothyroidism	0.00141	0.00875	CbGeAlD
Bexarotene—Abdominal pain—Liotrix—hypothyroidism	0.0014	0.00303	CcSEcCtD
Bexarotene—Body temperature increased—Liotrix—hypothyroidism	0.0014	0.00303	CcSEcCtD
Bexarotene—RXRA—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	0.00134	0.00355	CbGpPWpGaD
Bexarotene—Hypersensitivity—Liotrix—hypothyroidism	0.0013	0.00283	CcSEcCtD
Bexarotene—Asthenia—Liotrix—hypothyroidism	0.00127	0.00275	CcSEcCtD
Bexarotene—RXRA—NRF2 pathway—SLC5A5—hypothyroidism	0.00126	0.00333	CbGpPWpGaD
Bexarotene—Pruritus—Liotrix—hypothyroidism	0.00125	0.00271	CcSEcCtD
Bexarotene—Diarrhoea—Liotrix—hypothyroidism	0.00121	0.00262	CcSEcCtD
Bexarotene—Dizziness—Liotrix—hypothyroidism	0.00117	0.00254	CcSEcCtD
Bexarotene—RXRA—Gene Expression—ZNF764—hypothyroidism	0.00116	0.00306	CbGpPWpGaD
Bexarotene—Vomiting—Liotrix—hypothyroidism	0.00112	0.00244	CcSEcCtD
Bexarotene—Rash—Liotrix—hypothyroidism	0.00111	0.00242	CcSEcCtD
Bexarotene—Dermatitis—Liotrix—hypothyroidism	0.00111	0.00242	CcSEcCtD
Bexarotene—Headache—Liotrix—hypothyroidism	0.00111	0.0024	CcSEcCtD
Bexarotene—RXRA—Generic Transcription Pathway—NKX2-5—hypothyroidism	0.0011	0.00292	CbGpPWpGaD
Bexarotene—RXRA—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	0.00109	0.00288	CbGpPWpGaD
Bexarotene—RXRG—Gene Expression—NKX2-5—hypothyroidism	0.00108	0.00287	CbGpPWpGaD
Bexarotene—Nausea—Liotrix—hypothyroidism	0.00105	0.00228	CcSEcCtD
Bexarotene—RXRB—Gene Expression—NKX2-5—hypothyroidism	0.00102	0.0027	CbGpPWpGaD
Bexarotene—RXRA—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.00101	0.00267	CbGpPWpGaD
Bexarotene—RXRA—Generic Transcription Pathway—THRB—hypothyroidism	0.000998	0.00264	CbGpPWpGaD
Bexarotene—RXRG—Gene Expression—THRB—hypothyroidism	0.000981	0.00259	CbGpPWpGaD
Bexarotene—RXRB—Gene Expression—THRB—hypothyroidism	0.000922	0.00244	CbGpPWpGaD
Bexarotene—RXRA—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	0.000836	0.00221	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—CLTC—hypothyroidism	0.000824	0.00218	CbGpPWpGaD
Bexarotene—RXRA—Gene Expression—THRA—hypothyroidism	0.000746	0.00197	CbGpPWpGaD
Bexarotene—RXRA—Adipogenesis—IGF1—hypothyroidism	0.000696	0.00184	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—IYD—hypothyroidism	0.000682	0.0018	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—ATP5O—hypothyroidism	0.00058	0.00153	CbGpPWpGaD
Bexarotene—RXRA—Biological oxidations—POMC—hypothyroidism	0.000578	0.00153	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—TPO—hypothyroidism	0.000545	0.00144	CbGpPWpGaD
Bexarotene—RXRA—Gene Expression—NKX2-5—hypothyroidism	0.000531	0.0014	CbGpPWpGaD
Bexarotene—RXRA—Integrated Pancreatic Cancer Pathway—IGF1—hypothyroidism	0.000511	0.00135	CbGpPWpGaD
Bexarotene—RXRA—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	0.000505	0.00134	CbGpPWpGaD
Bexarotene—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	0.000501	0.00132	CbGpPWpGaD
Bexarotene—RXRA—Gene Expression—THRB—hypothyroidism	0.000481	0.00127	CbGpPWpGaD
Bexarotene—CYP2C9—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	0.000406	0.00107	CbGpPWpGaD
Bexarotene—RXRA—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	0.000404	0.00107	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—VAV3—hypothyroidism	0.000388	0.00103	CbGpPWpGaD
Bexarotene—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	0.000331	0.000874	CbGpPWpGaD
Bexarotene—RXRA—Transmembrane transport of small molecules—AVP—hypothyroidism	0.000318	0.00084	CbGpPWpGaD
Bexarotene—CYP3A4—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	0.000268	0.000708	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—IYD—hypothyroidism	0.000255	0.000673	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—TSHB—hypothyroidism	0.000252	0.000667	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—PIK3C2A—hypothyroidism	0.000225	0.000595	CbGpPWpGaD
Bexarotene—RXRA—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	0.000222	0.000587	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—ATP5O—hypothyroidism	0.000217	0.000572	CbGpPWpGaD
Bexarotene—CYP2C9—Biological oxidations—POMC—hypothyroidism	0.000216	0.00057	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—TPO—hypothyroidism	0.000204	0.000538	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—SLC5A5—hypothyroidism	0.000189	0.000499	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	0.000189	0.000499	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—IYD—hypothyroidism	0.000168	0.000444	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—ATP5O—hypothyroidism	0.000143	0.000377	CbGpPWpGaD
Bexarotene—CYP3A4—Biological oxidations—POMC—hypothyroidism	0.000142	0.000376	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—TPO—hypothyroidism	0.000134	0.000355	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—POMC—hypothyroidism	9.89e-05	0.000261	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—TSHB—hypothyroidism	9.43e-05	0.000249	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—PIK3C2A—hypothyroidism	8.4e-05	0.000222	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	8.29e-05	0.000219	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—SLC5A5—hypothyroidism	7.06e-05	0.000186	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—TSHB—hypothyroidism	6.22e-05	0.000164	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—PIK3C2A—hypothyroidism	5.54e-05	0.000146	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—SLC5A5—hypothyroidism	4.65e-05	0.000123	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—POMC—hypothyroidism	3.69e-05	9.76e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—POMC—hypothyroidism	2.43e-05	6.43e-05	CbGpPWpGaD
